Companies: 10,795·Total market cap: $144.5T
EBOS Group Limited

EBOS Group Limited

EBOSYOTCHealthcare● Active
$24.13
$-1.87(-7.19%)
Market Cap$1.2B
P/E Ratio
52W High$46.64
52W Low$24.13

EBOS Group Limited (EBOSY) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

EBOSY · cash on hand · updated Jun 30, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$183.2M -15.3% vs prior year
FY · as of Jun 30, 2025 · Reported in AUD
Cash & Cash Equiv. (CCE)
$183.2M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-15.3%
vs prior fiscal year
Latest Quarter
$250.1M
Q4 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in AUD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: June 30, 2025

Net cash vs debt

Cash & ST Investments$183.2MCash on Hand
Total Debt$1.61BTotal Debt
Net Cash / Net Debt−$1.43BNet Debt Position
Cash vs Debt Ratio
Cash 10%Debt 90%

EBOS Group Limited carries a net debt position of $1.43B. Total debt ($1.61B) exceeds cash on hand ($183.2M). EBOS Group Limited cash vs debt ratio: 10% cash / 90% debt.

Net Cash = Cash & ST Investments − Total Debt$183.2M$1.61B = −$1.43B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
EBOSY annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Jun 30, 2025Latest$183.2M-15.3%
Jun 30, 2024$216.2M+1.9%
Jun 30, 2023$212.1M-40.4%
Jun 30, 2022$355.7M+110.3%
Jun 30, 2021$169.2M-30.4%
EBOSY cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
EBOS Group Limited
EBOS Group LimitedYOU
EBOSY
$183.2M14.8%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

EBOS Group Limited (EBOSY) cash on hand as of June 30, 2025 is $183.2M, comprising $183.2M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as EBOS Group Limited cash and short-term investments on the balance sheet (10-K filing). Also referred to as EBOS Group Limited cash reserves or cash position.

EBOS Group Limited annual cash on hand history shows decreased -15.3% in 2025: decreased -15.3% in 2025. EBOS Group Limited cash reserves in 2025 reflect the company's capital allocation strategy.

EBOS Group Limited carries total debt of $1.61B against cash of $183.2M, resulting in a net debt position of -$1.43B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

EBOSY cash on hand · 5 questions

As of June 30, 2025, EBOS Group Limited (EBOSY) has $183,185,609 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $183,185,609 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2025): $250,052,696. Data sourced from the annual 10-K filing via FMP.

EBOSY cash on handEBOSY cash reservesEBOSY cash 2025how much cash does EBOSY have

Source: FMP /balance-sheet-statement · US GAAP · EBOS Group Limited · EBOS Group Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: June 30, 2025